CHARLES WYKOFF to Biomarkers, Tumor
This is a "connection" page, showing publications CHARLES WYKOFF has written about Biomarkers, Tumor.
Connection Strength
0.255
-
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol. 2001 Mar; 158(3):1011-9.
Score: 0.107
-
Atypical teratoid/rhabdoid tumor arising from the third cranial nerve. J Neuroophthalmol. 2008 Sep; 28(3):207-11.
Score: 0.045
-
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol. 2003 Jun; 200(2):222-8.
Score: 0.031
-
Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res. 2002 Dec; 8(12):3788-95.
Score: 0.030
-
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 2001 Aug 15; 19(16):3660-8.
Score: 0.028
-
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol. 2003 Feb 01; 21(3):473-82.
Score: 0.008
-
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer. 2002 Apr 22; 86(8):1276-82.
Score: 0.007